TherapeuticsMD, Inc.

NasdaqGS TXMD

TherapeuticsMD, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2024: -207.77%

TherapeuticsMD, Inc. Net Income Margin is -207.77% for the Trailing 12 Months (TTM) ending September 30, 2024. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

TherapeuticsMD, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -35.96%, a 80.96% change year over year.
TherapeuticsMD, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -188.82%, a 42.43% change year over year.
TherapeuticsMD, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was -327.98%, a 23.32% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

NasdaqGS: TXMD

TherapeuticsMD, Inc.

CEO	Mr. Marlan D. Walker J.D.
IPO Date	May 9, 2007
Location	United States
Headquarters	951 Yamato Road
Employees	1
Sector	Health Care
Industries Pharmaceuticals

Description

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Key trends

Past 5 years